Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Incepta Pharmaceuticals is a leading Bangladeshi pharmaceutical company established in 1999, specializing in the development, manufacturing, and marketing of generic drugs, vaccines, and biosimilars. Headquartered in Dhaka, the company operates state-of-the-art manufacturing facilities in Savar and Dhamrai, exporting its products to over 100 countries worldwide. Incepta is a significant contributor to global health initiatives, serving as a key partner in the WHO-led mRNA technology transfer hub and collaborating with organizations like the Bill & Melinda Gates Foundation. Their extensive portfolio covers over 1,200 generic products across therapeutic areas including oncology, infectious diseases, cardiovascular health, and neuroscience. The company is recognized for its advanced capabilities in producing complex dosage forms, such as lyophilized injections and pre-filled syringes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inccepta Pharmaceuticals.